Icon
Scientist

Student pharmacists advocate for provider status on Capitol Hill

The Pharmacy and Medically Underserved Areas Enhancement Act (H.R. 592/S. 109) is gaining more traction due to the efforts of student pharmacists who attended APhA Academy of Student Pharmacists’ (APhA-ASP) Summer Leadership Institute (SLI).

Per FDA, Major, Solco, and Teva recall all unexpired lots of valsartan, valsartan/hydrochlorothiazide

An impurity found in medications containing the active ingredient valsartan has prompted a voluntary recall of valsartan products by three generics manufacturers, FDA has announced. N-nitrosodimethylamine, which is classified as a probable human carcinogen, has been found in the recalled products and its appearance is thought to be related to changes in the way the active substance is manufactured.

FDA requires labeling changes for systemic fluoroquinolones

FDA has required class-wide safety labeling changes for oral and injectable fluoroquinolones to strengthen the warnings about the risks of adverse effects, including effects on mental health and blood glucose metabolism. A comprehensive review of FDA’s adverse event reports and case reports in the medical literature led to the requirement.

CDC’s ACIP discusses vaccines for influenza, HPV, and more

CDC’s Advisory Committee on Immunization Practices (ACIP) met in Atlanta on June 20–21 to review a variety of immunization topics, including influenza, HPV, and more. ACIP’s recommendations aren’t official until accepted by CDC and published in CDC’s Morbidity and Mortality Weekly Report.

New NIH initiative targets opioids

Equipped with $500 million from Congress, the National Institutes of Health (NIH) announced the launch of the HEAL (Helping to End Addiction Long-term) Initiative.

APhA Trustee at Trump administration roundtable on drug prices

At a recent federal roundtable convened by U.S. Sec. of Health and Human Services Alex Azar, APhA Trustee Theresa Tolle, BPharm, FAPhA, described the tough choices patients make when faced with high-cost medications and pharmacists’ role in controlling drug prices.